Evaluation the Efficacy and Safety of Mutiple Lenzumestrocel (Neuronata-R® Inj.) Treatment in Patients With ALS

NCT04745299 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

123

Enrollment

INDUSTRY

Sponsor class

Conditions

Amyotrophic Lateral Sclerosis

Interventions

BIOLOGICAL: Lenzumestrocel
DRUG: Riluzole
DRUG: Placebo Comparator

Sponsor

Corestemchemon, Inc.